| Madison Myers, | |
|
11832 Rock Landing Dr Ste 105, Newport News, VA 23606-4261 | |
| (757) 455-5000 | |
| Not Available |
| Full Name | Madison Myers |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 11832 Rock Landing Dr Ste 105, Newport News, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346939162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Jp Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851770598 PECOS PAC ID: 6709192503 Enrollment ID: O20150824001999 |
News Archive
Edward Calabrese, the University of Massachusetts Amherst environmental toxicologist who has been an outspoken critic of the current linear no-threshold (LNT) approach to risk assessment for radiation and toxic chemicals, now proposes a new approach integrating LNT with hormetic dose-response models.
Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.
NeoPharm, Inc. (Other OTC: NEOL.PK), announced today that it has reached a settlement agreement with Diosynth, RTP ("Diosynth"). As previously noted, NeoPharm reported that it had entered into various contractual arrangements with Diosynth to secure access to manufacturing capacity for the potential manufacture and regulatory advancement of Cintredekin Besudotox through early 2008.
Researchers at the University of California, San Diego, the Medical University of South Carolina, the University of Cincinnati, and American Life Science Pharmaceuticals of San Diego have validated the protease cathepsin B (CatB) as a target for improving memory deficits and reducing the pathology of Alzheimer's disease (AD) in an animal model representative of most AD patients.
Lucideon has released a new white paper titled ‘Additive Manufacturing – a Metallurgical Perspective'. The paper discusses the value and potential of metallurgical additive manufacturing alongside some of the challenges the technology needs to overcome.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Madison Myers, 95 Brettwood Ct, Williamsburg, VA 23185-4702 Ph: () - | Madison Myers, 11832 Rock Landing Dr Ste 105, Newport News, VA 23606-4261 Ph: (757) 455-5000 |
News Archive
Edward Calabrese, the University of Massachusetts Amherst environmental toxicologist who has been an outspoken critic of the current linear no-threshold (LNT) approach to risk assessment for radiation and toxic chemicals, now proposes a new approach integrating LNT with hormetic dose-response models.
Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.
NeoPharm, Inc. (Other OTC: NEOL.PK), announced today that it has reached a settlement agreement with Diosynth, RTP ("Diosynth"). As previously noted, NeoPharm reported that it had entered into various contractual arrangements with Diosynth to secure access to manufacturing capacity for the potential manufacture and regulatory advancement of Cintredekin Besudotox through early 2008.
Researchers at the University of California, San Diego, the Medical University of South Carolina, the University of Cincinnati, and American Life Science Pharmaceuticals of San Diego have validated the protease cathepsin B (CatB) as a target for improving memory deficits and reducing the pathology of Alzheimer's disease (AD) in an animal model representative of most AD patients.
Lucideon has released a new white paper titled ‘Additive Manufacturing – a Metallurgical Perspective'. The paper discusses the value and potential of metallurgical additive manufacturing alongside some of the challenges the technology needs to overcome.
› Verified 2 days ago
Martavius Collins, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 704 City Center Blvd, Newport News, VA 23606 Phone: 757-595-4880 | |
Nancy Milroy, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 11832 Rock Landing Dr #105, Newport News, VA 23606 Phone: 757-455-5000 | |
Emma Martone, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 11832 Rock Landing Dr, Newport News, VA 23606 Phone: 757-455-5000 | |
Sarah Clark, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 41 Old Oyster Point Rd Ste E, Newport News, VA 23602 Phone: 757-223-1466 Fax: 757-233-1467 | |
Kelcie Richburg, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 729 Thimble Shoals Blvd Ste 5-c1, Newport News, VA 23606 Phone: 757-863-9183 | |
Mrs. Phyllis R Ross, OTR/L, CHT, CLT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 11712 Jefferson Ave, Suite D, Newport News, VA 23606 Phone: 757-595-4880 Fax: 757-595-4886 | |
Mrs. Angela Marie Fitzgerald, MS, OTR, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 11848 Rock Landing Dr, Suite 303, Newport News, VA 23606 Phone: 757-873-8839 Fax: 757-873-1142 |